Spruce Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $16.4M | $45.2M | $38.8M |
| FY2025 | $10.5M | $53.0M | $48.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $16.4M | $45.2M | $38.8M |
| FY2025 | $10.5M | $53.0M | $48.9M |